Cyst(e)ine metabolism is a source of intracellular oxi dant stress (Astler et al,J Clin Invest 76:567,1985).Ws tudied the cyst(e)ine effect on platelet(plt)suspensions.Catalase activity of pIts incubated 60 min at37~: with 100 fM cyst(e)ine,l mM 3-amino-l,2,4-triazole(AT}, 0.2 mM DL-Buthionine-(S,R}-sulfoximine(inhibitor of gill tathione cycle)and then washed 3 times,was measured pl arographycally.Plt aggregation was performed by stan: dard method.Catalase activity(determined by 02genera-ted/mg protein after H 2 0 addition)was inhibited byaboti:
50% after cysteine,and b § about 30% after cystine addt ion(n=20,p(0.01)~Cysteineinhibited by 40% pIt aggregation,whereas cystine inhibited 2/3 of 20 samples.Thffi effect was partially reversed by externally added catl ase.The partial inhibition of catalase in the presence of AT indicates the production of H 2 0 2 (AT inhibits catalase only in the presence of II 0 ) .Our data suggest It is assumed that zinc absorption from human milk is better than from formulas. The question arises, if formulas should be enriched with additional zinc. We studied 10 breast-fed and 5 formula-fed infants in 72-hourbalances under home conditions. Collecting periods started 2, 5, 8, 12, and 16 weeks postnatally. The formula was supplemented with zinc sulphate and contained 3.98 mg/l Zn. Zn concentration in faeces, urine and milk samples was determined by atomic absorption spectrometry. The median of zinc values in human milk fell from 3.56 mg/l in the 3rd week to 1.2 mg/l in the 17th week of lactation. The median value of zinc intake in breast-fed infants declined from 0.566 mg/kgtd in the third week to 0.151 mg/kgtd in the 17th week. The median value of Zn intake in bottle fed infants remained between 0.597 and 0.707 mg/kgtd in the 5 collecting periods. Median values of Zn retention in the breast-fed infants ranged between 0.059 and 0.14 mg/kgtd, in the formula-fed infants between 0.043 and 0.306 mg/kgtd. Infants fed a supplemented formula with 3.98 mg/l Zn have a higher Zn intake, but approximately the same retention as breast-fed infants. This leads to the conclusion that a formula enriched with zinc (content 3.98 mg/l) is equivalent to breast milk concerning zinc retention. Nonenriched formulas contain approximately 1 mg/l zinc. Nutritional copper deficiencies have been described in breast-fed and formula-fed infants, yet balance data are scarce. We compared intake and retention of copper in three groups of infants: breast-fed (I), fed with adapted but not copper-supplemented formula (II) and fed with a supplemented formula. The mean copper concentration of these milks as determined by wet ashing and atomic absorption spectrometry was in breast-milk (I) 611 -1128 (depending on stage of lactation!), in (II) . The increag~of plasma-Cu after t=5 h post dose is due to incorporation of Cu in the plasma protein ce6~loplasmin: lower liver-eu results in a higher incorporation of eu (curve I versus 2). Application of the test to Wilson's disease (especially for early recognition) and some other -in part unexplained metabolic disorders affecting the Cu-metabolism -will be mentioned. A protocol wg~ch leads to acceptable exposures to eu will be given. Baitella-Eberle,G., Tuchschmid,P., Due,G. Dept. of Neonatology; Childrens Hospital, University of Zurich, Switzerland CI. -Tocopherol (Vitamin E=E) is the only antioxidant of red cell membranes. Its oxidation prevents damage of membrane phospholipids and proteins. E is transported in plasma and delivered to cell membranes by lipoproteins. We compared the oxidation of E in plasma (protein bound) and red cells (membranebound) with E in aqueous solution (solubilized with Deoxycholate =DOC). An enzymatic radical generating system was used to oxidize E under physiological conditions.
We found E protected completely from oxidation in plasma but sensitive when incorporated in cell membranes. A similar protection was found when E was bound either to serum albumin or to the different purified lipoproteins. It is oxidizable when solubilized in DOC and 4 different oxidation products were characterized by HPLC, one of which could be identified as tocopherylquinone. Similar oxidation products and oxidation rates were found for E in red cell membranes. These results suggest that E is easily accessible to oxidation in cell membranes but is protected by protein binding during transport in plasma. Menkes' (Kinky Hair) Disease, an inborn error of Cu-metabolism, is detectable in in vitro cultured skin fibroblasts. Such cells accumulate significant. more 64-Cu from the medium than control cells: the results of 9 otherwise verified patients and of 24 controls illustrate this (see Figure) .
Some unusual results of patients will be mentioned, among which one confirmed Menkes patient, which had unusual biochemical characteristics and a patient which had an unknown Cu-deficiency, different from Menkes' Disease.
Some complicating factors of the 64-Cu uptake will be discussed: the influence of confluency of the cultures, Cu content of the medium and the presence of such eu binding ligands as albumin.
